Prevention of carcinogen and inflammation-induced dermal cancer by oral rapamycin includes reducing genetic damage

Cancer prevention is a cost-effective alternative to treatment. In mice, the mechanistic target of rapamycin (mTOR) inhibitor rapamycin prevents distinct spontaneous, non-inflammatory cancers, making it a candidate broad-spectrum cancer prevention agent. We now show that oral microencapsulated rapam...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Prev Res (Phila)
Autori principali: Dao, Vinh, Pandeswara, Srilakshmi, Liu, Yang, Hurez, Vincent, Dodds, Sherry, Callaway, Danielle, Liu, Aijie, Hasty, Paul, Sharp, Zelton D., Curiel, Tyler J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4417432/
https://ncbi.nlm.nih.gov/pubmed/25736275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-14-0313-T
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi